Your session is about to expire
← Back to Search
Olympus VE2 NIR Imaging System for Lung Cancer
Study Summary
This trial will assess whether NIR imaging can help doctors identify and assess perfusion of the gastric conduit and segmental anatomy during minimally invasive esophagectomy and pulmonary segmentectomy.
- Lung Cancer
- Esophageal Lesion
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
What is the aggregate number of individuals participating in this trial?
"Affirmative. Information located on clinicaltrials.gov verifies that recruiting for this study is still ongoing, with an initial post date of October 29th 2020 and a recent update to the listing in April 2022. 45 patients are being sought out at 1 medical centre."
Is recruitment currently in progress for this experiment?
"Affirmative, the trial is still open for recruitment. It was initially posted on October 29th 2020 and last edited on April 20th 2022. The research team seeks 45 participants from a single site."
Share this study with friends
Copy Link
Messenger